Jie Xu, Yameng Cui, Lianmin Zhang, Shengguang Wang, Zhanyu Pan, Zhansheng Jiang. "Firmonertinib combined with cisplatin/carboplatin plus pemetrexed as neoadjuvant therapy in resectable stage II-IIIb
                    <i>EGFR</i>
                    -mutated non–small cell lung cancer: A single-arm, single-center, open-label phase II study.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.8058